England increases Pandemik preparation with the new vaccination factory | Science, Climate and Technical News
A US vaccination company opened its first MRNA manufacturing facility in the UK against the increasing rhetoric against Jab.
Apart from Oxford, the new facility is part of an investment of 1 billion pounds by Modernna, specialized in MRNA.
New vaccine technology COVİD PANDEM.
Many pharmaceutical companies, including Germany’s leading MRNA pioneer, Biongtech, are now competing to develop new therapies.
Moderna says the facility will produce up to 100 million doses each year from existing vaccine products. In addition, in case of a new disease epidemic, production is designed to scale 250 million dose per year.
“If there is another epidemic, we can change the facility every day, S
The UK Investment Agreement was accepted by the previous government, but the opening of the facility is a pleasant relief for the present.
In recent weeks, four major pharmaceutical companies have stopped planned investments in the UK Following the disagreements of drug pricing and profitability in the UK.
‘A great expression’
In addition, when dangerous supply outages threaten the early Covid response, it promises to restore domestic vaccine production capacity in the UK.
“This is a really fast way to discover these new vaccines,” he said, former Chief Scientist and now Science Minister Lord Patrick Vallance.
“It is also a great expression of trust in the UK [Moderna has] He chose to base themselves here. “
Moderna: England still believes in vaccines’
The MRNA molecule is the same as used by our cells to order the production of new proteins and allows vaccines to be produced by using genetic code of only one virus or other biological target.
Modernna’s investment decision prevented Donald Trump from returning to the White House, but Modernna CEO may pay dividends in the UK’s operation in England – a “still believed in vaccination” if it turns into a lack of demand for its products in the anti -vaccine rhetorical USA.
“If there are less appetite to use vaccines by governments in the world, including the USA, we can invest less in vaccines.” He said.
“We should invest in a demand for our products.”
Read More: All health claims made by Trump – and what do experts say
Please use the Chrome browser for a more accessible video player
Are we politics fueling a deadly measles epidemic?
The UK offers other attraction centers for the company, which has significant losses because the demand for the Covid vaccine has fallen.
He bets that the leading UK universities and a large patient population will do for successful clinical research.
The company has seasonal influenza, a combination Covid and influenza vaccine, cancer vaccines and NHS for MRNA therapies for two inherited MRNA therapies.
Moderna says that clinical research in the UK is the largest private commercial sponsor.
